Home > Insider Trading > Filing (0001628280-25-001204)

Filing Details

Accession Number:: 0001628280-25-001204
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-01-10 18:45:07
Reporting Period:: 2025-01-07

Accepted Time:: 2025-01-10 18:45:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1104506	Insmed Inc	INSM	Pharmaceutical Preparations (2834)	541972729

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1930805	Drayton John Wise	700 Us Highway 202/206 Bridgewater NJ 08807	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2025-01-07	10,000	$16.07	132,492	No	4	M	Direct
Common Stock	Disposition	2025-01-07	10,000	$65.98	122,492	No	4	S	Direct
Common Stock	Disposition	2025-01-07	2,908	$65.87	119,584	No	4	S	Direct
Common Stock	Disposition	2025-01-08	392	$66.21	119,192	No	4	S	Direct
Common Stock	Acquisiton	2025-01-08	6,657	$0.00	125,849	No	4	A	Direct
Common Stock	Disposition	2025-01-10	287	$65.40	125,562	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2025-01-07	10,000	$0.00	10,000	$16.07
Common Stock	Stock Option (right to buy)	Acquisiton	2025-01-08	31,930	$0.00	31,930	$65.72

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2025-01-08	No	4	M	Direct
31,930		2035-01-08	No	4	A	Direct

Footnotes

This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Includes 835 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees.
This is the weighted average sales price representing 2,908 shares sold at prices ranging from $65.84 to $65.93 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.
Each RSU was granted on January 8, 2025 for no consideration.
The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.